Jean Y Wang

Title: Jean Y Wang: Innovator in Leukemia Detection Methods

Introduction

Jean Y Wang is a prominent inventor based in San Diego, California. She has made significant contributions to the field of medical diagnostics, particularly in the detection of leukemia. Her innovative work has led to the development of methods that enhance the understanding and treatment of this serious condition.

Latest Patents

Jean Y Wang holds a patent for "Methods for the detection of BCR-ABL and abnormal ABL proteins." This invention provides methods for detecting and quantifying BCR-ABL gene products and other abnormal ABL gene products in Ph.sup.1-positive leukemic cells. The patent also outlines methods for determining the relative number of leukemic cells compared to normal ABL cells, which is crucial for assessing the tumor burden in patients. Additionally, her methods can be utilized to identify specific phases of leukemia, particularly chronic-phase chronic myeloid leukemia (CML).

Career Highlights

Jean Y Wang is affiliated with the University of Texas System, where she continues her research and development in medical diagnostics. Her work has been instrumental in advancing the understanding of leukemia and improving patient outcomes through innovative detection methods.

Collaborations

Some of her notable coworkers include Ralph B Arlinghaus and Jie O Guo, who have collaborated with her on various research projects.

Conclusion

Jean Y Wang's contributions to the field of leukemia detection are invaluable. Her innovative methods not only enhance diagnostic capabilities but also play a crucial role in patient care. Her work exemplifies the impact of innovation in the medical field.